Cetera Investment Advisers - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cetera Investment Advisers ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$7,927,000
+6.2%
119,565
+0.0%
0.11%
-4.2%
Q3 2021$7,464,000
-14.9%
119,562
+12.9%
0.12%
-15.6%
Q2 2021$8,772,000
+16.3%
105,920
-6.9%
0.14%
-4.7%
Q1 2021$7,545,000
-14.6%
113,788
-1.1%
0.15%
-15.4%
Q4 2020$8,831,000
+1006.6%
115,090
+521.2%
0.18%
+169.2%
Q3 2020$798,000
+14.5%
18,526
+14.8%
0.06%0.0%
Q2 2020$697,00016,1350.06%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders